Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy?

Thrombosis and Haemostasis

Volumn 81, Issue 3, 1999, Pages 378-381

  Boberg, Kirsten Muri ^a   Brosstad, Frank ^a   Egeland, Thore ^a   Egge, Tor ^a   Schrumpf, Erik ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BLEEDING TIME; BONE MARROW TRANSPLANTATION; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK;

EID: 0033013104     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614481     Document Type: Article

References (32)

1. Barber A, Green D, Galluzzo T, Ts'ao C-H. The bleeding time as a preoperative screening test. Am J Med 1985; 78: 761-4.
2. Burns ER, Lawrence C. Bleeding time. A guide to its diagnostic and clinical utility. Arch Pathol Lab Med 1989, 113: 1219-24.
3. Rodgers RPC, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990; 16: 1-20.
4. Lind SE. The bleeding time does not predict surgical bleeding. Blood 1991; 77: 2547-52.
5. De Caterina R, Lanza M, Manca G, Strata GB, Maffei S, Salvatore L. Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding. Blood 1994; 84: 3363-70.
6. Triplett DA. The bleeding time. Neither pariah or panacea. Arch Pathol Lab Med 1989; 113: 1207-8.
7. Ferraris VA, Gildengorin V. Predictors of excessive blood loss use after coronary bypass grafting. J Thorac Cardiovasc Surg 1989, 98: 492-7.
8. Editorial. The bleeding time. Lancet 1991; 337: 1447-8.
9. Piceinino F, Sagnelli E, Pasquale G, Giusti G, Complications following percutaneous liver biopsy. A multicentre retrospective study on 68276 biopsies. J Hepatol 1986, 2: 165-73.
10. McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990; 99: 1396-1400.
11. Buscarini L, Fornari F, Bolondi L, Colombo P, Livraghi T, Magnolfi F, Rapaccini GL et al. Ultrasound-guided fine-needle biopsy of focal liver lesions: techniques, diagnostic accuracy and complications. A retrospective study on 2091 biopsies. J Hepatol 1990; 11: 344-8.
12. Sugano S, Sumino Y, Hatori T, Mizugami H, Kawafune T, Abei T. Incidence of ultrasound-detected intrahepatic hematomas due to tru-cut needle liver biopsy. Dig Dis Sci 1991; 36: 1229-33.
13. Janes CH, Lindor KD. Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med 1993; 118: 96-8.
14. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 1995; 36: 43741.
15. Violi F, Leo R. Vezza E, Basili S. Cordova C, Balsano F, C.A.L.C. Group. Bleeding time in patients with cirrhosis: relation with degree of liver failure and clotting abnormalities. J Hepatol 1994; 20: 531-6.
16. Hsu W-C. Lee F-Y. Lee S-D. Tsai Y-T. Lin H-C. Lin R-S. Meng H-C et al. Prolonged bleeding time in cirrhotic patients, relationship to peripheral vasodilation and severity of cirrhosis. J Gastroenterol Hepatol 1994; 9: 437-41.
17. Sherlock S, Dooley J. Needle biopsy of the liver. In Diseases of the liver and biliary system. Sherlock S, Dooley J, eds. Oxford: Blackwell Scientific Publications 1997: 33-42.
18. Ishak KG, Schiff ER. Schiff L. Needle biopsy of the liver. In: Diseases of the liver, Schiff L, Schiff ER, eds. Philadelphia: J. B. Lippincott 1987: 399-441.
19. Mielke CH Jr., Kaneshiro MM, Maher IA. Weiner JM. Rapaport SI. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969; 34: 204-5.
20. McVay PA, Toy PTCY. Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol 1990; 94: 747-53.
21. Altman DG. Practical statistics for medical research. London: Chapman & Hall. 1991.
22. S-PLUS User's Manual, Version 3.3. for Windows. Seattle: Statistical Sciences. Inc., 1995.
23. Makris M, Nakielny R, Toh CH, Hampton KK, Triger DR, Greaves M. A prospective investigation of the relationship between haemorrhagic complications of percutaneous needle biopsy of the liver and coagulation screening tests (Abstract). Int Soc Haemalol 1992; 199A.
24. Sharma P, McDonald GB, Banaji M. The risk of bleeding after percutaneous liver biopsy: relation to platelet count. J Clin Gastroenterol 1982; 4: 451-3.
25. Sherlock S, Dick R, Van Leeuwen DJ, Liver biopsy today. The Royal Free Hospital experience. J Hepatol 1984; 1: 75-85.
26. Ewe K, Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 1981; 26: 388-93.
27. Dillon JF, Simpson KJ, Hayes PC. Liver biopsy bleeding time: an unpredictable event. J Gastroenterol Hepatol 1994; 9: 269-71.
28. McGill DB. Predicting hemorrhage after liver biopsy. Editorial. Dig Dis Sci 1981; 26: 385-7.
29. Caturelli E, Squillante MM, Andriulli A, Siena DA, Cellerino C. De Luca F, Marzano MA et al. Fine-needle liver biopsy in patients with severely impaired coagulation. Liver 1993; 13: 270-3.
30. Harker LA. Slichter SJ. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972; 287: 155-9.
31. Sánchez-Roig MJ, Rivera J, Moraleda JM, Garcia VV, Quantitative defect of glycoprotein Ib in severe cirrhotic patients. Am J Hematol 1994; 45: 10-5.
32. Mammen EF, Comp PC, Gosselin R, Greenberg C, Hoots WK, Kessler CM. Larkin EC et al. PFA-100™ system: a new method for assessment of platelet dysfunction. Semin Thromb Hemostas 1998; 24: 195-202.